Operant behavioral treatment of fibromyalgia: A controlled study

Arthritis Care and Research

Volumn 49, Issue 3, 2003, Pages 314-320

  Thieme, Kati ^a   Gromnica Ihle, Erika ^a   Flor, Herta ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Behavior therapy; Fibromyalgia; Operant treatment; Pain

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DRUG UTILIZATION; EVALUATION; FEMALE; FIBROMYALGIA; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; INSTRUMENTAL CONDITIONING; LENGTH OF STAY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PAIN ASSESSMENT; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SLEEP TIME; SPOUSE; TECHNIQUE;

EID: 0037975534     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11124     Document Type: Article

References (28)

1. Wolfe F, Smythe HA, Yunus MB, Benett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Smythe HA, Moldovsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977;28:928-31.
3. White KP, Speechley M, Ostbye T. The London fibromyalgia epidemiology study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999;26:1577-85.
4. Dohrenbusch R, Gruterich M, Genth E. Fibromyalgia and Sjögren syndrome - clinical and methodological aspects. Z Rheumatol 1996;55:19-27.
5. Crofford LJ. The hypothalamic-pituitary-adrenal stress-axis in the fibromyalgia-syndrome. J Musculoskel Pain 1996;4:181-200.
6. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 2000;41:104-13.
7. Papadopoulos IA, Georgiou PE, Katsimbri PP, Drosos AA. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study. Clin Rheumatol 2000;19:6-8.
8. Smith AJ. The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol 1998;12:407-13.
9. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis and fibromyalgia. Arthritis Rheum 2000;43:378-85.
10. Flor H, Birbaumer N. Comparison of the efficacy of electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculoskeletal pain. J Consult Clin Psychol 1993;61:653-8.
11. Nicassio PM, Radojevic V, Weisman MH, Schuman C, Kim J, Schoenfeld-Smith K, et al. A comparison of behavioral and educational interventions for fibromyalgia. J Rheumatol 1997;24:2000-7.
12. Nielson WR, Walker C, McCain GA. Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings. J Rheumatol 1992;19:98-103.
13. Turk DC, Okifuji A, Sinclair JD, Starz, TW. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res 1998;11:186-95.
14. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 1999;21:180-91.
15. Flor H. Psychobiologie des Schmerzes [Psychobiology of pain]. Bern: Verlag Hans Huber; 1991.
16. Vlaeyen JWS, Haazen IWCJ, Kole-Snijders AMJ, van Eek, H, Schuerman JA. Behavioral rehabilitation of chronic low back pain: comparison of an operant treatment, an operant-cognitive treatment and an operant-respondent treatment. Br J Clin Psychol 1995;34:95-118.
17. Fordyce WE. Behavioral methods in chronic pain and illness. St. Louis: Mosby; 1976.
18. Turk DC, Okifuji A, Sinclair JD, Starz TW. Pain, disability and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 1996;23:1255-62.
19. Flor H, Rudy TE, Birbaumer N, Streit B, Schugens MM. Zur Anwendbarkeit des West Haven-Yale Multidimensional Pain Inventory im deutschen Sprachraum: Daten zur Reliabilität und Validität des MPI-D. [The applicability of the West Haven-Yale Multidimensional Pain Inventory in German-speaking countries: data on the reliability and validity of the MPID]. Der Schmerz 1990;4:82-7.
20. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985;23:345-56.
21. Flor H, Heimerdinger K. Erfassung von Schmerzverhalten. [Assessment of pain behavior]. In: Geissner E, Jungnitsch G, editors. Psychologie des Schmerzes [Psychology of pain]. Weinheim: Psychologie Verlags Union; 1992. p. 99-106.
22. Flor H, Birbaumer N. Psychobiologie und interdisziplinäre Therapie chronischer Wirbelsäulensyndrome [Psychobiology and interdisciplinary treatment of chronic back pain]. München: GSF Forschungszentrum; 1994.
23. Turner JA, Jensen MP. Efficacy of cognitive therapy for chronic low back pain. Pain 1993;52:169-77.
24. Jacobson NS, Follette WC, Revenstorf D. Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance. Behav Ther 1984;15:336-52.
25. Flor H, Fydrich Th, Turk D. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 1992;49:221-30.
26. Elam M, Johansson G, Wallin BG. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992;48:371-5.
27. Qiao Z, Vaeroy H, Morkrid L. Elektrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 1991;18:1383-9.28.
28. Vaeroy H, Qiao ZG, Morkrid L, Forre O. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989;16:1460-5.